India to South Africa Pharmaceutical Export (2026) — $749.1M, 350 Suppliers | TransData Nexus

India to South Africa Pharmaceutical Export (2026) — $749.1M, 350 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to South Africa

#	Formulation	Value	Share
1	Duolin Respules 2.5ml (ipratropium Bromide 0.5mg+salbutamol Sulphate 2.5mg (per…	$26.8M	3.6%
2	Atroiza (tenofovir Disoproxil Fumarate 300mg + Efavirenz 600mg + Emtricitabine…	$13.2M	1.8%
3	Zoxil 250 (amoxicillin 250mg Capsules BP	$12.1M	1.6%
4	Dolutegravir+lamivudine+tenofovir Disoprtablets	$11.0M	1.5%
5	Rifampicin 150mg / Isoniazid 75mg / Ethambutol Hydrochloride 275mg Tablets Bno:…	$10.4M	1.4%
6	Zoxil Sf 100ml Syrup (amoxicillin Oral S	$7.3M	1.0%
7	Volmaro 10 MG Tablets (ambrisentan 10mg)	$6.8M	0.9%
8	Delamanid Tablets 50mg 48bl Za My (3585 Packs X6x8s=172080nos)	$6.7M	0.9%
9	Pneumococcal Polysaccharide	$6.5M	0.9%
10	Dumiva (abacavir Sulfate 600mg + Lamivudine 300mg Tablets) (28s) (41295 Packs X…	$5.7M	0.8%
11	Triolar Tablets Bno:beb92310a Md.10/23 Ed.09/25 Ps: 1x30s	$5.3M	0.7%
12	Triolar Tablets Bno:beb92309a Md.09/23 Ed.08/25 Ps: 1x30s	$4.8M	0.6%
13	Flat Pouches 61mm X 131 Mm ( 60gsm Pape	$4.8M	0.6%
14	Coricib 90mg Tablets Each Tablets Contains Etoricoxib 90mg Pack: 4x7s	$4.7M	0.6%
15	Syromak 1x30s (78874 Pac)	$4.5M	0.6%

India exports 18+ pharmaceutical formulations to South Africa with a combined trade value of $749.1M. Key products include Tenofovir ($13.2M), Amoxicillin ($12.1M), Dolutegravir ($11.0M), Rifampicin ($10.4M), Efavirenz ($5.3M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 23,527 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to South Africa Trade Routes

1Tenofovir$13.2M 2Amoxicillin$12.1M 3Dolutegravir$11.0M 4Rifampicin$10.4M 5

Top Indian Exporters to South Africa

1Cipla Limited

$132.9M

2Macleods Pharmaceuticals Ltd

$67.1M

3Mylan Laboratories Limited

$61.5M

4Adcock Ingram Limited

$50.6M

5Sun Pharmaceutical Industries Limited

Port Analysis — India to South Africa Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)16.4%

NHAVA SHEVA SEA1.1%

SAHAR AIR12.5%

JNPT/ NHAVA SHEVA SEA8.2%

JNPT6.3%

South Africa Import Ports

Durban25.5%

DURBAN28.7%

JOHANNESBURG - JOHAN16.1%

CAPE TOWN12.9%

Cape Town6.0%

Trade Statistics

Total Value$749.1M

Shipments23,527

Indian Exporters350

South Africa Buyers892

Avg Shipment$32K

Products13,948

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–South Africa Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and South Africa has experienced significant growth over the past decade. In 2024, India exported pharmaceutical products valued at approximately $668.99 million to South Africa, marking a substantial increase from previous years. This upward trajectory underscores the strengthening bilateral trade relations and India's expanding footprint in the South African pharmaceutical market.

Key milestones in this evolution include the establishment of robust distribution networks and the alignment of Indian pharmaceutical standards with South African regulatory requirements. The presence of major Indian pharmaceutical companies in South Africa has facilitated the introduction of a diverse range of products, catering to the country's healthcare needs. This growth is also attributed to India's competitive pricing and the high quality of its pharmaceutical offerings.

2India's Market Position

India holds a dominant position in South Africa's pharmaceutical import landscape. In 2024, India was one of the main trade partners of South Africa concerning pharmaceutical imports, with a share of just over 50 percent. This substantial market share highlights India's strategic importance as a supplier of high-quality, cost-effective pharmaceutical products.

The Indian pharmaceutical sector's adherence to international quality standards and its ability to offer a wide array of generic medicines have bolstered its standing in the South African market. This competitive edge is further enhanced by India's compliance with Good Manufacturing Practices (GMP), ensuring the safety and efficacy of its products.

South Africa Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in South Africa must navigate SAHPRA's structured application process. The process involves submitting a Health Product Application (HPA) through SAHPRA's Engagement Portal, accompanied by comprehensive documentation, including a Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and evidence of Good Manufacturing Practice (GMP) compliance. (sahpra.org.za)

The registration dossier should adhere to the Common Technical Document (CTD) format, encompassing modules on administrative information, quality data, non-clinical and clinical study reports, and labeling. SAHPRA evaluates the safety, efficacy, and quality of the product based on this dossier. The review timeline varies depending on the application type and data completeness but typically ranges from several months to over a year.

2GMP & Facility Requirements

SAHPRA mandates that manufacturing facilities comply with GMP standards to ensure product quality and safety. Indian manufacturers must undergo inspections by SAHPRA or recognized regulatory authorities to verify adherence to these standards. The inspection process assesses various aspects, including facility design, equipment, personnel qualifications, and quality control measures. Mutual recognition agreements between SAHPRA and other regulatory bodies can expedite this process for manufacturers with existing certifications.

3Import Documentation

To import pharmaceutical products into South Africa, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): Confirms the product's registration and compliance with manufacturing standards in the country of origin.

Certificate of Analysis (CoA): Details the product's composition and quality control results.

Good Manufacturing Practice (GMP) Certificate: Demonstrates that the manufacturing facility adheres to recognized GMP standards.

These documents facilitate customs clearance and ensure that imported medicines meet South Africa's regulatory requirements. Additionally, compliance with SAHPRA's guidelines for the importation and exportation of medicines is essential to prevent delays and ensure market access. (sahpra.org.za)

TransData Nexus Research · South Africa regulatory databasesMar 2026

FAQ — India to South Africa Pharmaceutical Trade

What is the total value of India's pharmaceutical export to South Africa?

India exported pharmaceuticals worth $749.1M to South Africa across 23,527 verified shipments.

Who are the top Indian pharmaceutical exporters to South Africa?

1. CIPLA LIMITED — $132.9M. 2. MACLEODS PHARMACEUTICALS LTD — $67.1M. 3. MYLAN LABORATORIES LIMITED — $61.5M. Total: 350 suppliers.

Which companies in South Africa import pharmaceuticals from India?

1. MEDPRO PHARMACEUTICA (PTY) LTD — $52.6M. 2. ADCOCK INGRAM LIMITED — $43.2M. 3. VIATRIS HEALTHCARE (PTY) LTD, — $29.5M. 892 buyers total.

What pharmaceutical products does India export most to South Africa?

1. Duolin Respules 2.5ml (ipratropium Bromide 0.5mg+salbutamol Sulphate 2.5mg (per… ($26.8M, 3.6%); 2. Atroiza (tenofovir Disoproxil Fumarate 300mg + Efavirenz 600mg + Emtricitabine… ($13.2M, 1.8%); 3. Zoxil 250 (amoxicillin 250mg Capsules BP ($12.1M, 1.6%); 4. Dolutegravir+lamivudine+tenofovir Disoprtablets ($11.0M, 1.5%); 5. Rifampicin 150mg / Isoniazid 75mg / Ethambutol Hydrochloride 275mg Tablets Bno:… ($10.4M, 1.4%)

Which ports handle pharmaceutical shipments from India to South Africa?

Export: NHAVA SHEVA SEA (INNSA1), NHAVA SHEVA SEA, SAHAR AIR, JNPT/ NHAVA SHEVA SEA, JNPT. Import: Durban, DURBAN, JOHANNESBURG - JOHAN, CAPE TOWN, Cape Town.

Why does South Africa import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $749.1M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply South Africa?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to South Africa pharmaceutical trade?

$31.8K per consignment across 23,527 shipments.

How many Indian pharmaceutical companies export to South Africa?

350 Indian companies. Largest: CIPLA LIMITED with $132.9M.

How can I find verified Indian pharmaceutical suppliers for South Africa?

TransData Nexus covers 350 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to South Africa identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 23,527 verified shipments from 350 Indian exporters to 892 South Africa buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

350 Exporters

892 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to South Africa Pharmaceutical Export

Top Pharmaceutical Formulations — India to South Africa

Top Pharmaceutical Products — India to South Africa Trade Routes

Top Indian Exporters to South Africa

Port Analysis — India to South Africa Pharmaceutical Shipments

Indian Export Ports

South Africa Import Ports

Trade Statistics

Other Destinations

India–South Africa Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Top South Africa Buyers from India

Product Routes

Full Dataset Access

3Recent Developments

South Africa Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to South Africa

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and South Africa

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to South Africa Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — South Africa for Indian Pharma

1Market Size & Growth

2Healthcare System